A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMID 17660072)

Published in J Am Coll Surg on June 27, 2007

Authors

William C Chapman1, Neil Singla, Yuri Genyk, James W McNeil, Kenneth L Renkens, Thomas C Reynolds, Aileen Murphy, Fred A Weaver

Author Affiliations

1: Department of Surgery, Section of Transplantation, Washington University, St Louis School of Medicine, St Louis, MO 63110, USA.

Associated clinical trials:

Study of Recombinant Human Thrombin for Bleeding During Surgery | NCT00245336

Articles citing this

Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents. Am J Obstet Gynecol (2015) 1.98

Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins. PLoS One (2012) 0.94

Clinical use of topical thrombin as a surgical hemostat. Biologics (2008) 0.93

Soft materials to treat central nervous system injuries: evaluation of the suitability of non-mammalian fibrin gels. Biochim Biophys Acta (2009) 0.92

Self-propelled particles that transport cargo through flowing blood and halt hemorrhage. Sci Adv (2015) 0.89

Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Invest Surg (2013) 0.86

Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature. Patient Saf Surg (2008) 0.85

Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding. Ann Surg Innov Res (2009) 0.85

Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety. Patient Saf Surg (2009) 0.82

A novel hemostatic sealant composed of gelatin, transglutaminase and thrombin effectively controls liver trauma-induced bleeding in dogs. Acta Pharmacol Sin (2013) 0.81

Thrombin use in surgery: an evidence-based review of its clinical use. J Blood Med (2010) 0.79

Safety of topical thrombins: the ongoing debate. Patient Saf Surg (2009) 0.78

A heuristic approach and heretic view on the technical issues and pitfalls in the management of penetrating abdominal injuries. Scand J Trauma Resusc Emerg Med (2010) 0.78

Modification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich Plasma. PLoS One (2016) 0.77

Newer hemostatic agents used in the practice of dermatologic surgery. Dermatol Res Pract (2013) 0.75

Bovine thrombin and the clinical consequence of antibody development. J Am Coll Surg (2008) 0.75

Improved bleeding scores using Gelfoam(®) Powder with incremental concentrations of bovine thrombin in a swine liver lesion model. J Thromb Thrombolysis (2016) 0.75

Efficacy of a topical bovine-derived thrombin solution as a hemostatic agent in a rodent model of hepatic injury. Can J Vet Res (2015) 0.75

Hemostatic effect and distribution of new rhThrombin formulations in rats. Interdiscip Toxicol (2015) 0.75

Skin and Skin Structure Infections, And Control of Hemostasis during Surgery. P T (2008) 0.75

Articles by these authors

(truncated to the top 100)

Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69

Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11

Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut (2011) 2.65

Measuring sexual orientation in adolescent health surveys: evaluation of eight school-based surveys. J Adolesc Health (2004) 2.58

Hazards of stigma: the sexual and physical abuse of gay, lesbian, and bisexual adolescents in the United States and Canada. Child Welfare (2006) 2.34

Sexual orientation, sexual abuse, and HIV-risk behaviors among adolescents in the Pacific Northwest. Am J Public Health (2006) 2.29

A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg (2007) 1.94

Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol (2006) 1.83

Forty-eight hours of postoperative pain relief after total hip arthroplasty with a novel, extended-release epidural morphine formulation. Anesthesiology (2005) 1.82

Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol (2011) 1.60

Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg (2009) 1.58

Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial. Anesth Analg (2011) 1.51

Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation. Pediatr Blood Cancer (2009) 1.48

Late outcomes of endovascular and open revascularization for nonatherosclerotic renal artery disease. Arch Surg (2010) 1.46

Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO). J Vasc Surg (2010) 1.46

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum Gene Ther (2002) 1.40

Intraoperative umbilical herniorrhaphy during liver transplantation. Surgery (2008) 1.40

Alternate method to secure the aorta for organ perfusion in donation after cardiac death donors. Transpl Int (2008) 1.39

Caval preservation with reconstruction of the hepatic veins using caval-common iliac bifurcation graft for domino liver transplantation. Liver Transpl (2006) 1.38

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther (2003) 1.36

Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res (2009) 1.36

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol (2004) 1.25

Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg (2009) 1.17

Extended pancreatectomy with resection of the celiac axis: the modified Appleby operation. Am J Surg (2006) 1.12

Hypoplasia of the descending thoracic and abdominal aorta: a report of two cases and review of the literature. J Vasc Surg (2002) 1.10

Anticoagulation is an effective treatment for aortic mural thrombi. J Vasc Surg (2002) 1.04

Surgical management of complicated hydatid disease of the liver. Am Surg (2002) 1.02

Safety of carbon dioxide digital subtraction angiography. Arch Surg (2011) 1.00

Racial and ethnic differences in patterns of treatment for acute peripheral arterial disease in the United States, 1998-2006. J Vasc Surg (2010) 1.00

Transfusion free surgery: single institution experience of 27 consecutive liver transplants in Jehovah's Witnesses. J Am Coll Surg (2005) 0.96

Pharmacokinetic profile of liposome bupivacaine injection following a single administration at the surgical site. Clin Drug Investig (2013) 0.96

Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin. J Am Coll Surg (2009) 0.95

Endovascular management of mycotic aortic aneurysms and associated aortoaerodigestive fistulas. Ann Vasc Surg (2008) 0.94

Arch and visceral/renal debranching combined with endovascular repair for thoracic and thoracoabdominal aortic aneurysms. J Vasc Surg (2011) 0.94

Repair of a blunt traumatic inferior vena cava laceration with commercially available endografts. J Vasc Surg (2006) 0.94

Clinical use of topical thrombin as a surgical hemostat. Biologics (2008) 0.93

Concomitant vascular procedures for malignancies with vascular invasion. Arch Surg (2002) 0.93

Unusual cases of jaundice secondary to non-neoplastic bile duct obstruction. Am Surg (2004) 0.93

A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil. Eur Urol (2004) 0.93

Internal jugular, subclavian, and axillary deep venous thrombosis and the risk of pulmonary embolism. Vascular (2008) 0.92

Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application. Ann Surg (2004) 0.90

Live donor liver transplantation: staging hepatectomy in a Jehovah's Witness recipient. J Hepatobiliary Pancreat Surg (2004) 0.90

Endovascular management of hoarseness due to a thoracic aneurysm: case report and review of the literature. Vasc Endovascular Surg (2008) 0.90

Carbon dioxide digital subtraction angiography-assisted endovascular aortic aneurysm repair in the azotemic patient. J Vasc Surg (2007) 0.89

Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference. Clin Ther (2003) 0.89

Assessing the performance of surgical teams. Health Care Manage Rev (2008) 0.88

Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen. J Virol (2005) 0.88

Randomized, prospective, and controlled clinical trial of pulsed electromagnetic field stimulation for cervical fusion. Spine J (2007) 0.88

Disease progression after initial surgical intervention for Takayasu arteritis. J Vasc Surg (2011) 0.87

Race independently impacts outcome of infrapopliteal bypass for symptomatic arterial insufficiency. Vasc Endovascular Surg (2007) 0.87

To do or not to do living donor hepatectomy in Jehovah's Witnesses: single institution experience of the first 13 resections. Am J Transplant (2005) 0.87

A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis. J Am Coll Surg (2009) 0.87

The surgical management of pancreatic cancer. Gastroenterol Clin North Am (2012) 0.87

Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at standard surgical risk: results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke (2012) 0.87

Basilic vein transposition fistula: a good option for maintaining hemodialysis access site options? J Vasc Surg (2004) 0.86

Endovascular management of iliac vein occlusive disease. Ann Vasc Surg (2004) 0.86

Current trends in the management of iatrogenic cervical carotid artery injuries. Vasc Endovascular Surg (2006) 0.86

Repair of a high-flow iliac arteriovenous fistula using a thoracic endograft. J Vasc Surg (2009) 0.86

Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher. Transplantation (2013) 0.85

Clinical outcomes and implications of failed infrainguinal endovascular stents. J Vasc Surg (2011) 0.85

Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes. Vaccine (2002) 0.85

Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction. J Card Fail (2010) 0.85

At what price? A cost-effectiveness analysis comparing trial of labour after previous caesarean versus elective repeat caesarean delivery. PLoS One (2013) 0.85

Rupture of a previously thrombosed thoracoabdominal aneurysm. Ann Vasc Surg (2003) 0.85

Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. Clin Ther (2007) 0.84

The effects of shoulder laxity on upper extremity blood flow in professional baseball pitchers. J Shoulder Elbow Surg (2010) 0.84

Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers. Urology (2005) 0.84

Totally laparoscopic aortobifemoral bypass: a review of 22 cases. J Vasc Surg (2005) 0.83

Smooth muscle cells improve endothelial cell retention on polytetrafluoroethylene grafts in vivo. J Vasc Surg (2003) 0.83

Regional quality groups in the Society for Vascular Surgery® Vascular Quality Initiative. J Vasc Surg (2013) 0.83

Clinical importance of the "seat belt sign" in blunt trauma to the neck. Am Surg (2002) 0.83

Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: malignant or benign pathology? Report of a case. Surg Today (2007) 0.82

Impact of race on infrainguinal angioplasty and stenting. Ann Vasc Surg (2011) 0.82

A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesth Analg (2012) 0.82

Characteristics and management of splenic artery aneurysm in liver transplant candidates and recipients. Am Surg (2003) 0.81

Comparison of outcomes in noncomplicated and in higher-risk donors after standard versus hand-assisted laparoscopic nephrectomy. Am Surg (2003) 0.81

Surgical teams: role perspectives and role dynamics in the operating room. Health Serv Manage Res (2011) 0.81

Protecting the privacy of third-party information: recommendations for social and behavioral health researchers. Soc Sci Med (2006) 0.80

Major hepatobiliary surgery during pregnancy: safety and timing. Am Surg (2005) 0.80

Transfusion-free techniques in pediatric live donor liver transplantation. J Pediatr Gastroenterol Nutr (2005) 0.80

The results of a needs assessment to guide a vascular surgery skills simulation curriculum. Ann Vasc Surg (2012) 0.80

Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia. J Vasc Surg (2008) 0.80

Treatment options for traumatic pseudoaneurysms of the paravisceral abdominal aorta. Ann Vasc Surg (2005) 0.80

Combined surgical resection and radiofrequency ablation as treatment for metastatic ocular melanoma. Surg Today (2012) 0.80

Thrombin use in surgery: an evidence-based review of its clinical use. J Blood Med (2010) 0.79

Acute arterial occlusion secondary to trauma. Semin Vasc Surg (2009) 0.79

Pancreaticoduodenectomy in adults with congenital intestinal rotation disorders. Pancreas (2005) 0.78

Left portahepatic shunt: a novel technique to decrease excessive portal venous inflow during live donor liver transplantation. J Am Coll Surg (2003) 0.78

A phase I trial of alfimeprase for peripheral arterial thrombolysis. J Vasc Interv Radiol (2005) 0.78

Day care compared with inpatient management of nausea and vomiting of pregnancy: a randomized controlled trial. Obstet Gynecol (2014) 0.78

Hepatoblastoma in a patient with methylmalonic aciduria. Am J Med Genet A (2015) 0.77

A prospective study of carbon dioxide digital subtraction versus standard contrast arteriography in the detection of endoleaks in endovascular abdominal aortic aneurysm repairs. Ann Vasc Surg (2013) 0.77

Renal Denervation in Heart Failure. Curr Hypertens Rep (2015) 0.77

Restricting fresh frozen plasma in hepatic resections. J Am Coll Surg (2003) 0.77

Inhibition of Notch signaling by Dll4-Fc promotes reperfusion of acutely ischemic tissues. Biochem Biophys Res Commun (2012) 0.77

Thoracic aortic stent-grafting for acute, complicated, type B aortic dissections. Ann Vasc Surg (2011) 0.77

Recombinant human coagulation factor VIIa in Jehovah's Witness patients undergoing liver transplantation. Am Surg (2005) 0.77

Development of a flexible implantable sensor for postoperative monitoring of blood flow. J Ultrasound Med (2012) 0.76

Impact of a transfusion-free program on non-Jehovah's Witness patients undergoing liver transplantation. Arch Surg (2006) 0.76

Injury induced neointima formation and its inhibition by retrovirus-mediated transfer of nitride oxide synthase gene in an in-vitro human saphenous vein culture model. Atherosclerosis (2002) 0.76